These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Adipocytes affect castration-resistant prostate cancer cells to develop the resistance to cytotoxic action of NK cells with alterations of PD-L1/NKG2D ligand levels in tumor cells. Xu L, Shen M, Chen X, Zhu R, Yang DR, Tsai Y, Keng PC, Chen Y, Lee SO. Prostate; 2018 Apr; 78(5):353-364. PubMed ID: 29330929 [Abstract] [Full Text] [Related]
4. ATM‑JAK‑PD‑L1 signaling pathway inhibition decreases EMT and metastasis of androgen‑independent prostate cancer. Zhang L, Xu LJ, Zhu J, Li J, Xue BX, Gao J, Sun CY, Zang YC, Zhou YB, Yang DR, Shan YX. Mol Med Rep; 2018 May; 17(5):7045-7054. PubMed ID: 29568923 [Abstract] [Full Text] [Related]
6. A Crosstalk Between Castration-Resistant Prostate Cancer Cells, M2 Macrophages, and NK Cells: Role of the ATM-PI3K/AKT-PD-L1 Pathway. Jin H, Zhu J, Xuan R, Zhou Y, Xue B, Yang D, Gao J, Zang Y, Xu L. Immunol Invest; 2023 Nov; 52(8):941-965. PubMed ID: 37732622 [Abstract] [Full Text] [Related]
10. Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis. Ou ZL, Luo Z, Wei W, Liang S, Gao TL, Lu YB. RNA Biol; 2019 Nov; 16(11):1592-1603. PubMed ID: 31402756 [Abstract] [Full Text] [Related]
11. Protein kinase D3 regulates the expression of the immunosuppressive protein, PD‑L1, through STAT1/STAT3 signaling. Cui B, Chen J, Luo M, Wang L, Chen H, Kang Y, Wang J, Zhou X, Feng Y, Zhang P. Int J Oncol; 2020 Apr; 56(4):909-920. PubMed ID: 32319563 [Abstract] [Full Text] [Related]
12. HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines. Okita R, Mougiakakos D, Ando T, Mao Y, Sarhan D, Wennerberg E, Seliger B, Lundqvist A, Mimura K, Kiessling R. J Immunol; 2012 Mar 01; 188(5):2136-45. PubMed ID: 22301547 [Abstract] [Full Text] [Related]
13. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways. Neilson LM, Zhu J, Xie J, Malabarba MG, Sakamoto K, Wagner KU, Kirken RA, Rui H. Mol Endocrinol; 2007 Sep 01; 21(9):2218-32. PubMed ID: 17550976 [Abstract] [Full Text] [Related]
14. Inhibition of glycogen synthase kinase-3 increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of STAT3. Fionda C, Malgarini G, Soriani A, Zingoni A, Cecere F, Iannitto ML, Ricciardi MR, Federico V, Petrucci MT, Santoni A, Cippitelli M. J Immunol; 2013 Jun 15; 190(12):6662-72. PubMed ID: 23686482 [Abstract] [Full Text] [Related]
15. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression. Song H, Kim J, Cosman D, Choi I. Cell Immunol; 2006 Jan 15; 239(1):22-30. PubMed ID: 16630603 [Abstract] [Full Text] [Related]
16. Docetaxel suppresses immunotherapy efficacy of natural killer cells toward castration-resistant prostate cancer cells via altering androgen receptor-lectin-like transcript 1 signals. Tang M, Gao S, Zhang L, Liu B, Li J, Wang Z, Zhang W. Prostate; 2020 Jul 15; 80(10):742-752. PubMed ID: 32449811 [Abstract] [Full Text] [Related]
17. STAT3 inhibition by STA21 increases cell surface expression of MICB and the release of soluble MICB by gastric adenocarcinoma cells. Garrido-Tapia M, Hernández CJ, Ascui G, Kramm K, Morales M, Ga Rate V, Zúñiga R, Bustamante M, Aguillón JC, Catala N D, Ribeiro CH, Molina MAC. Immunobiology; 2017 Nov 15; 222(11):1043-1051. PubMed ID: 28578917 [Abstract] [Full Text] [Related]
18. Loss of JAK1 Drives Innate Immune Deficiency. Witalisz-Siepracka A, Klein K, Prinz D, Leidenfrost N, Schabbauer G, Dohnal A, Sexl V. Front Immunol; 2018 Nov 15; 9():3108. PubMed ID: 30671064 [Abstract] [Full Text] [Related]
20. Hypoxia Impairs NK Cell Cytotoxicity through SHP-1-Mediated Attenuation of STAT3 and ERK Signaling Pathways. Teng R, Wang Y, Lv N, Zhang D, Williamson RA, Lei L, Chen P, Lei L, Wang B, Fu J, Liu X, He A, O'Dwyer M, Hu J. J Immunol Res; 2020 Nov 15; 2020():4598476. PubMed ID: 33123602 [Abstract] [Full Text] [Related] Page: [Next] [New Search]